Back
Grace Therapeutics, Inc. Stock Price Chart
Get Your Free Stock Selector Checklist and Invest Smarter
Get Your Free Safe Stock Selector Checklist Now
Sell
44
GRCE
Grace Therapeutics, Inc.
Last Price:
$3.47
Seasonality Move:
-16.02%
7 Day Trial
ALL ACCESS PASS
$
7
Safe Investing Checklist - Stay Clear of Risky Stocks
Get Your Free Safe Stock Selector Checklist Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GRCE is experiencing buying pressure, which is a positive indicator for future bullish movement.
Grace Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.21 | Buy |
| 20-day SMA: | 3.14 | Buy |
| 50-day SMA: | 3.1 | Buy |
| 200-day SMA: | 2.91 | Buy |
| 8-day EMA: | 3.23 | Buy |
| 20-day EMA: | 3.15 | Buy |
| 50-day EMA: | 2.68 | Buy |
| 200-day EMA: | 1.19 | Buy |
Grace Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.12 | Buy |
| Relative Strength Index (14 RSI): | 63.5 | Buy |
| Chaikin Money Flow: | 65802 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.03 - 3.21) | Buy |
| Bollinger Bands (100): | (3.01 - 3.23) | Buy |
Grace Therapeutics, Inc. Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Grace Therapeutics, Inc. Stock
Is Grace Therapeutics, Inc. Stock a Buy?
-
Grace Therapeutics, Inc. share price is 3.35 while GRCE 8-day simple moving average is 3.21, which is a Buy signal.
-
The stock price of GRCE is 3.35 while Grace Therapeutics, Inc. 20-day SMA is 3.14, which makes it a Buy.
-
Grace Therapeutics, Inc. 50-day simple moving average is 3.10 while GRCE share price is 3.35, making it a Buy technically.
-
GRCE stock price is 3.35 and Grace Therapeutics, Inc. 200-day simple moving average is 2.91, creating a Buy signal.
GRCE Technical Analysis vs Fundamental Analysis
Sell
44
Grace Therapeutics, Inc. (GRCE)
is a Sell
Is Grace Therapeutics, Inc. a Buy or a Sell?
-
Grace Therapeutics, Inc. stock is rated a SellThe current Grace Therapeutics, Inc. [GRCE] share price is $3.35. The Score for GRCE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Grace Therapeutics, Inc. Stock Info
Market Cap:
51.8M
Price in USD:
3.35
Share Volume:
65.8K
Grace Therapeutics, Inc. 52-Week Range
52-Week High:
4.69
52-Week Low:
1.75
Sell
44
Grace Therapeutics, Inc. (GRCE)
is a Sell
Grace Therapeutics, Inc. Share Price Forecast
-
What is the Grace Therapeutics, Inc. stock price today?The Grace Therapeutics, Inc. stock price is 3.35 USD today.
-
Will GRCE stock go up or go down?Grace Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Grace Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Grace Therapeutics, Inc. is overvalued.
Is Grace Therapeutics, Inc. Stock a Buy?
-
Grace Therapeutics, Inc. share price is 3.35 while GRCE 8-day exponential moving average is 3.23, which is a Buy signal.
-
The stock price of GRCE is 3.35 while Grace Therapeutics, Inc. 20-day EMA is 3.15, which makes it a Buy.
-
Grace Therapeutics, Inc. 50-day exponential moving average is 2.68 while GRCE share price is 3.35, making it a Buy technically.
-
GRCE stock price is 3.35 and Grace Therapeutics, Inc. 200-day simple moving average is 1.19, creating a Buy signal.
Fundamental Analysis of Grace Therapeutics, Inc.
Is Grace Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.23 per share, and an increase next year of $0.31 per share.
Technical Analysis of Grace Therapeutics, Inc.
Should I short Grace Therapeutics, Inc. stock?
-
GRCE Moving Average Covergence Divergence (MACD) indicator is 0.12, suggesting Grace Therapeutics, Inc. is a Buy
-
Grace Therapeutics, Inc. Relative Strength Index (RSI) is 63.5, which suggest Grace Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Grace Therapeutics, Inc. is (3.03 - 3.21), which suggest Grace Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Grace Therapeutics, Inc. is (3.01 - 3.23), which suggest Grace Therapeutics, Inc. is a Buy
* Grace Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.